Biomeme is excited to announce that we have signed a definitive agreement to acquire Predigen, a spin-out from Duke University and global leader...

Biomeme’s move into its new corporate headquarters at Netrality's 401 North Broad Street, will begin an exciting new chapter for our company.  

We are pleased to announce that the U.S. Food and Drug Administration (FDA) amended Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

This is a very common question, so let’s get straight to it.

We are proud to announce our new SARS-CoV-2 Mutation Panel 1.0 (RUO) to help researchersepidemiologists, and local, state, and federal health...

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

List of SARS-CoV-2 Variants & Classifications

Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates...

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month...

When you walk into Biomeme HQ in Philadelphia, you’ll find a bustling office overflowing with our staff, incoming and outgoing packages, and an...

Content not found